Ligand Reports Fourth Quarter and Full Year 2024 Financial Results

Go back to Ligand Reports Fourth Quarter and Full Year 2024 Financial Results
LIGAND PHARMA (NASDAQ: LGND) Delayed: 289.74 --0 (-0%)
Previous Close $289.74    52 Week High $139.79 
Open $289.74    52 Week Low $82.07 
Day High $289.74    P/E 673.81 
Day Low $289.74    EPS $0.43 
Volume 1,685       

(NASDAQ: VRNA) Delayed: 106.91 --0 (-0%)
Previous Close $106.91    52 Week High
Open $106.91    52 Week Low
Day High $106.91    P/E N/A 
Day Low $106.91    EPS
Volume 2,620